Product Recalls: March 15, 2023 – April 12, 2023
Health Letter, May 2023
Note: Never stop taking a drug that appears on the product recall list without first talking to your doctor or pharmacist. Most recalls are limited to a single manufacturer and may not be related to the version of a particular drug you are taking. If a recall does relate to the version of the drug you are taking, you should not stop taking the drug until you discuss an alternative treatment with your doctor or pharmacist.
CLASS I
CLASS II
Alprazolam tablets; 0.25, 0.5, 1 or 2 mg; 30-, 60- or 90-count bottle. Manufactured by: Breckenridge Pharmaceuticals, Inc., or Packaged and Distributed By: Direct Rx. Lot #: G1822K, exp. date: 5/31/2023; Lot #: D2022P, exp. date: 4/30/2023; Lot #: F1022Y, E2022 or I2822U, exp. date: 6/30/2023; Lot #: L2122W, exp. date: 8/31/2024; Lot #: L0522A, exp. date: 8/31/2024; Lot #: B0823J, exp. date: 11/31/2024; Lot #: L1522P, exp. date: 10/31/2024; Lot #: H3122D, exp. date: 8/31/2024; Lot #: A1123R, L0522E, J2622H, I1622F or H2422E, exp. date: 8/31/2024; Lot #: 11AP2219, exp. date: 4/30/23; Lot #: 03FE2318, exp. date: 8/31/24; Lot #: 27FE2315, 28FE2313, 02MA2306, 21SE2201, 16NO2216, 17NO2216 or 24FA2314, exp. date: 8/31/24; Lot #: 17FE2203, 12AP2204 or 17MA2205, exp. date: 3/31/23; Lot #: 21JU2206, 22JU2220 or 12JY2206, exp. date: 5/31/23; Lot #: 10AU2209, exp. date: 6/30/23; Lot #: 14DE2215, exp. date: 9/30/24; Lot #: 05JA2304 or 27JA2301, exp. date: 11/30/24; Lot #: 03FE2319, exp. date: 2/28/25, Lot #: 13MY2217, exp. date: 5/31/23.
Aripiprazole tablets, 5 mg, 30-count bottles. Repackaged by: RemedyRepack Inc. Lot #: J0620431-052322, exp. date: 05/31/23.
Atorvastatin calcium tablets, 10 or 20 mg, 30- or 90-count bottle. Manufactured by: Accord Healthcare, Inc., or Repackaged by: RemedyRepack Inc. Lot #: A0523D, exp. date: 5/31/2024, Lot #: F14220, exp. date: 7/31/2023; Lot #: J0622Q, exp. date: 1/31/2024; Lot #: B1522B, exp. date: 4/30/2023; Lot #: C0222H or C0322B, exp. date: 5/31/2023; Lot #: E1022H, F13220 or H2222P, exp. date: 6/30/2023; Lot#: I1422V or K01220, exp. date: 12/31/2023; Lot #: L2722H, exp. date: 3/31/2024; Lot #: C0322B, exp. date: 5/31/2023; Lot #: H1122G or 12322Q, exp. date: 6/30/2023; Lot #: J1222U, exp. date 12/31/2023; Lot #: J0679046-020123, exp. date: 02/28/2024; Lot #: J0669807-122122, exp. date: 01/31/2024; Lot #: J0662695-112222, exp. date: 12/31/2023; Lot #: J0654076-101822 or J0654076-101822, exp. date: 11/30/2023; Lot #: J0642765-082922, exp. date: 09/30/2023; Lot #: B1672408-050322, B1765902-071322 or B1769634-071622, exp. date: 04/30/2023; Lot #: B1776907-072122, exp. date: 09/30/2023; Lot #: B1836636-090322, exp. date: 11/30/2023; Lot #: B1870344-092422, exp. date: 01/31/2024; Lot #: B1908452-101522, B1966455-111722 or B2043099-010423, exp. date: 05/31/2024; Lot #: J0659819-110922, exp. date: 11/30/2023; Lot #: J0649932-093022 or J0649917-093022, exp. date: 10/31/2023, Lot #: B2010060-121222, exp. date: 03/31/24; Lot #: B1708575-060122, exp. date: 05/31/2023; Lot #: B1879236-092922, exp. date: 12/31/2023.
Clopidogrel tablets, 75 mg, 90-count bottles. Manufactured: Accord Healthcare, Inc. Lot #: E0922W, G1222E, I0922W or K3022W, exp. date: 10/31/2023.
Dabigatran etexilate capsules, 75 or 150 mg, 60 capsules per bottle. Manufactured by: Alkem Laboratories Ltd. Lot #: 22142462, 22142463 or 22142464, exp. date: 5/2024; Lot #: 22143000, 22143001 or 22143002, exp. date: 6/2024; Lot #: 22142448, 22142449 or 22142450, exp date: 5/2024; Lot #: 22143845, exp. date: 7/2024.
Doxazosin tablets; 2 or 4 mg; 30-, 90- or 100-count bottle. Manufactured by: Accord Healthcare, Inc., or Repackaged by: RemedyRepack Inc. Lot #: H3122K, exp. date: 5/31/2024; Lot #: L1522V, exp. date: 4/30/2025; Lot #: J0665197-120522, exp. date: 12/31/2023; Lot #: J0642497-082722, exp. date: 09/30/2023; Lot #: J0638552-080922, exp. date: 08/31/2023; Lot #: B1808799-081622, exp. date: 05/31/2024.
Finasteride tablets, 5 mg, 30- or 90-count bottle. Packaged and Distributed By: Direct Rx or Manufactured by: Accord Healthcare, Inc. Lot #: 19AU2205, exp. date: 12/31/24; Lot #: 12OC2211, exp. date: 12/31/24; Lot #: A1321V or D0221J, exp. date: 8/31/2023; Lot #: A1322J, exp. date: 5/31/2024; Lot #: F0221Q, I0121E, I1021R or J1122D, exp. date: 10/31/2023; Lot #: B0422J, exp. date: 5/31/2024; Lot #: C1721K, exp. date: 8/31/2023; Lot #: K1022Q, exp. date: 11/30/2024.
Glimepiride tablets; 1, 2 or 4 mg; 30-, 90- or 180-count bottle. Packaged and Distributed By: Direct Rx or Manufactured by: Accord Healthcare, Inc.. Lot #: 07MA2208, exp. date: 5/31/2024; Lot #: 09AU2128, exp. date: 1/31/2024; Lot #: 28JY2102, exp. date: 1/31/2024; Lot #: 06AU2103, exp. date: 1/31/2024; Lot #: 03JA2210, exp. date: 1/31/2024; Lot #: 14JY2114, exp. date: 1/31/2024; Lot #: 05NO2106, exp. date: 2/29/2024; Lot #: 13OC2118, exp. date: 2/29/2024; Lot #: 08DE2121, exp. date: 2/29/2024; Lot #: 21JU2112, exp. date: 9/30/2023; Lot #: 22DE2113, exp. date: 1/31/2024; Lot #: 27JA2235, exp. date: 3/31/2024; Lot #: 05AP2224, exp. date: 7/31/2024; Lot #: 06AU2104, exp. date: 1/31/2024; Lot #: 08JU2215, exp. date: 9/30/2024; Lot #: 209AU2109, exp. date: 1/31/2024; Lot #: 15JU2113, exp. date: 9/30/2023; Lot #: 21FE2217, exp. date: 4/30/2024; Lot #: 21OC2115, exp. date: 2/29/2024; Lot #: 23JY2144, exp. date: 1/31/2024; Lot #: 25JU2124, exp. date: 9/30/2023; Lot #: 29AP2219, exp. date: 7/31/2024; Lot #: 07DE2128, exp. date: 3/31/2024; Lot #: 13DE2111, exp. date: 3/31/2024; Lot #: 17NO2116, exp. date: 1/31/2024; Lot #: 27JA2234, exp. date: 4/30/2024; Lot #: 02MA2218, exp. date: 6/30/2024; Lot #: 12MY2211, exp. date: 7/31/2024; Lot #: 13JY2107, exp. date: 10/31/2023; Lot #: 15AP2221, exp. date: 7/31/2024; Lot #: 17AU2110, exp. date: 10/31/2023; Lot #: 20SE2108, exp. date: 10/31/2023; Lot #: 23JU2115, exp. date: 10/31/2023; Lot #: 28JY2101, exp. date: 10/31/2023; Lot #: 30JY2101, exp. date: 10/31/2023; Lot #: 05JA2212, exp. date: 3/31/2024; Lot #: 13DE2130, exp. date: 3/31/2024; Lot #: 21OC2111, exp date: 1/31/2024; Lot #: 17NO2116, exp. date: 3/31/2024; Lot #: D0122K, exp. date: 6/30/2024; Lot #: I1422N, exp. date: 9/30/2024; Lot #: I2721B, exp. date: 1/31/2024; Lot #: H1221Z, I0121J or J0622X, exp. date: 10/31/2023; Lot #: J0674153-010923, exp. date: 01/31/2024; Lot #: J0649447-092822, exp. date: 10/31/2023; Lot #: J0644887-090722, exp. date: 09/30/2023; Lot #: J0627309-062222, exp. date: 06/30/2023; Lot #: J0622569-060222, exp. date: 06/30/2023; Lot #: B1646259-041222, exp. date: 04/30/2023; Lot #: B2032846-122722, exp. date: 01/31/2025; Lot #: B2018675-121722, exp. date: 05/31/2025; Lot #: B1708230-060122 or B1709748-060122, exp. date: 06/30/2023; Lot #: B1692572-051822, exp. date: 05/31/2023; Lot #: B1803110-081122, exp. date: 12/31/2024; Lot #: B1820672-082422 or B1814883-082022, exp. date: 09/30/2024.
JARDIANCE (empagliflozin) tablets, 25 mg, 30- or 90-count bottles. Marketed by: Boehringer Ingelheim Pharmaceuticals, Inc., and Eli Lilly and Company. Lot #: E61835, exp. date: JUN 2025.
Montelukast sodium tablets; 10 mg; 30-, 60- or 90-count bottle. Packaged and Distributed By: Direct Rx or Manufactured by: Accord Healthcare, Inc. Lot #: 20JU2211, exp date: 5/31/2024; Lot #: 25JU2128, exp. date: 12/31/2023; Lot #: 13SE2132, exp. date: 12/31/2023; Lot #: 25JU2133, exp. date: 12/31/2023; Lot #: 16JU2127, exp. date: 12/31/2023; Lot #: 18MY2126, exp. date: 12/31/2023; Lot #: 10JU2111, exp. date: 12/31/2023; Lot #: 14SE2111, exp. date: 1/31/2024; Lot #: 14JY2115, exp. date: 1/31/2024; Lot #: 25OC2113, exp. date: 2/29/2024; Lot #: 21SE2227, exp. date: 2/29/2024; Lot #: 10DE2123, exp. date: 3/31/2024; Lot #: 22NO2115, exp. date: 3/31/2024; Lot #: 21JA2202, exp. date: 4/30/2024; Lot #: 29DE2110, exp. date: 4/30/2024; Lot #: 28FE2227, exp. date: 4/30/2024; Lot #: 06JU2208, exp. date: 5/31/2024; Lot #: 30MA2229, exp. date: 5/31/2024; Lot #: 30AU2216, exp. date: 6/30/2024; Lot #: 23NO2203, exp. date: 6/30/2024; Lot #: 14DE2216, exp. date: 7/31/2025; Lot #: 12JA2305, exp. date: 7/31/2025; Lot #: F3021D, exp. date: 12/31/2023, Lot #: L0722T, exp. date: 5/31/2025; Lot#: F1021I, exp. date: 12/31/2023; Lot #: H1721R, exp. date: 12/31/2023, Lot #: L0722E, exp. date: 5/31/2025.
Pravastatin sodium tablets, 20 mg, 90-count bottle. Manufactured for: Accord Healthcare, Inc. Lot #: F1021I or H3122J, exp. date: 4/30/2024.
Ropinirole tablets; 0.25, 0.5, 1 or 2 mg; 30-, 90- or 190-count bottle. Packaged and Distributed by: Direct Rx or Repackaged by: RemedyRepack Inc. Lot #: 21JU2210, exp. date: 7/31/23; Lot #: 22JU2216, exp. date: 8/31/23; Lot #: B1789178-080122, exp. date: 07/31/2023; Lot #: B1675475-050522, exp. date: 05/31/2023; Lot #: B1630017-040122, exp. date: 04/30/2023.
Rosuvastatin tablets; 5, 10 or 40 mg; 30-, 45- or 90-count bottle. Manufactured: Accord Healthcare, Inc., or Repackaged by: RemedyRepack Inc. Lot #: F2022N, exp. date: 2/29/2024; Lot #: F0322I, exp. date: 8/31/2023; Lot #: J1322H, exp. date: 2/29/2024; Lot #: K0222N, exp. date: 6/30/2024; Lot #: L2322D or L2822J, exp. date: 7/31/2025; Lot #: A1723C, exp. date: 8/31/2025; Lot #: A1922B, exp. date: 6/30/2024; Lot #: D0622M or F2922I, exp. date: 7/31/2024; Lot #: G3021L, exp. date: 1/31/2024; Lot #: H2622P or J0722C, exp. date: 10/31/2024; Lot #: J0668398-121422, exp. date: 12/31/2023; Lot #: J0661225-111522 or J0654053-101822, exp. date: 11/30/2023; Lot #: J0646383-091422, exp. date: 09/30/2023; Lot#: J0674788-011123, exp. date: 01/31/2024; Lot #: J0664118-112922 or J0664118-112922, exp. date: 12/31/2023; Lot #: J0653727-101722, exp. date: 10/31/2023. Lot #: B2057931-011223, exp. date: 07/31/2025; Lot #: B2075815-012523, exp. date: 09/30/2025; Lot #: B2011634-121322, exp. date: 07/31/2025; Lot #: B1970205-112022, exp. date: 06/30/2024; Lot #: B1862598-092022, exp. date: 03/31/2024; Lot #: B2077226-012523 or B2070444-012023, exp. date: 07/31/2025; Lot #: B2038806-123022, B2014185-121422 or B1925528-102522, exp. date: 07/31/2025. Lot #: B2080829-012823, B1938007-110222 or B2038746-123022, exp. date: 07/31/2025.
Simvastatin tablets; 5, 10, 20, 40 or 80 mg; 30-, 60- or 90-count bottle. Packaged and Distributed By: Direct Rx or Manufactured for: Accord Healthcare, lnc., or Repackaged by: RemedyRepack Inc. Lot #: 03JA2209, 28FE2225, 28AP2211 or 07AP2203, exp. date: 6/30/23; Lot #: 05AU2206, exp. date: 10/31/23; Lot #: 30MA2213, exp. date: 6/30/23; Lot #: 10DE2124, exp. date: 3/31/23; Lot #: 15MA2224, exp. date: 5/32/23; Lot #: 27JA2229, exp. date: 3/31/23; Lot #: 09JA2312, exp. date: 2/28/2025; Lot #: 22OC2111, exp. date: 1/31/2023; Lot #: 13OC2120, exp. date: 3/31/2023; Lot #: 16JY2104, exp. date: 12/31/2023; Lot #: 09AU2125, exp. date: 1/31/2024; Lot #: 28JY2125, exp. date: 1/31/2024; Lot #: 23SE2115, exp. date: 3/31/2024; Lot #: 23SE2115, exp. date: 3/31/2024; Lot #: 07JA2211, exp. date: 5/31/2024; Lot #: 27JA2214, exp. date: 5/31/2024; Lot #: 15AP2224, exp. date: 6/30/2024; Lot #: 24MA2221, exp. date: 6/30/2024; Lot #: 16AU2214, exp. date: 6/30/2024; Lot #: 28AP2212, exp. date: 7/31/2024; Lot #: 24MA2230, exp. date: 7/31/2024; Lot #: 11JA2203, exp. date: 3/31/2023; Lot #: 02FE2217, exp. date: 2/28/2023; Lot #: 10DE2126, exp. date: 2/28/2023; Lot #: 25MA2201, exp. date: 5/31/2023; Lot #: 28FE2230, exp. date: 5/31/2023; Lot #: C2222P, D1522L, E3122D or G2522J, exp. date: 9/30/2023; Lot #: J1222R, exp. date: 10/31/2023; Lot #: B0222S, exp. date: 2/29/2024; Lot #: F1121B or G2721L, exp. date: 11/30/2023; Lot #: A0923R, exp. date: 2/28/2025; Lot #: A1222K or B1822C, exp. date: 5/31/2024; Lot #: C3022D or F2322V, exp. date: 6/30/2024; Lot #: H1522H, exp. date: 8/31/2024; Lot #: I1621O, exp. date: 1/31/2024; Lot #: I2222G or J1822R, exp. date: 9/30/2024; Lot #: L1621N, exp. date: 5/31/2024; Lot #: F0822Q, exp. date: 6/30/2024, Lot #: I0122J, exp. date: 8/31/2024, Lot #: L0821C, exp. date: 5/31/2024; Lot #: I1521P, exp. date: 1/31/2024; Lot #: J1322R, exp. date: 9/30/2024; Lot #: J1821H, exp. date: 2/29/2024; Lot #: B0922G, exp. date: 5/31/2023; Lot #: F0322G, exp. date: 7/25/2024; Lot #: H2622M, exp. date: 8/31/2024; Lot #: J1422B or K0722G, exp. date: 10/31/2024; Lot #: L1922A, exp. date: 2/28/2025; Lot #: F2922S, exp. date: 8/31/2023; Lot #: H0322G, exp. date: 7/31/2023; Lot #: A1322I, exp. date: 3/31/2023; Lot #: H1122C, exp. date: 8/31/2024; Lot #: J0675206-011223 or J0669260-121922, exp. date: 01/31/2024; Lot #: J0656820-103122 or J0647161-091722, exp. date: 09/30/2023 or 11/30/2023; Lot #:J0621491-052722, exp. date: 06/30/2023; Lot #: J0638138-080822, exp. date: 08/31/2023; Lot #: J0610887-041122, exp. date: 04/30/2023. Lot #: B1887315-100422, exp. date: 02/28/2024; Lot #: B1829906-083122 or B1769715-071622, exp. date: 09/30/2023; Lot#: B1906605-101422, exp. date: 02/28/2024; Lot #: B1965118-111622, exp. date: 02/28/2025; Lot #: J0656821-103122, exp. date: 11/30/2023; J0638547-080922, Exp. Date 08/31/2023; J0633575-071822, Exp. Date 07/31/2023 Lot #: b): B1965081-111622, Exp. Date 03/31/2025; B1857922-091922, B1765298-071322, B1786319-072922, B1706842-053122, Exp. Date 04/30/2023; B2003311-120822, Exp. Date 04/30/2025; B1955679-111122, Exp. Date 02/28/2025; B1878942-092922, Exp. Date 11/30/2024; B1823203-082622. Exp. Date 10/31/2024; B1706843-053122, Exp. Date 05/31/2023.
Tadalafil tablets, 5 or 20 mg, 7- or 30-count bottle. Manufactured for: Accord Healthcare, lnc., or Repackaged by: RemedyRepack Inc. Lot #: C0822E, exp. date: 1/31/2024; Lot #: F1121B, exp. date: 1/31/2024; Lot #: G2721L, exp. date: 1/31/2024; Lot #: B1635780-040522, exp. date: 04/30/2023.
For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.
CONSUMER PRODUCTS
For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.